Hence, LSD1 inhibitors exhibit antitumor effects by derepressing ERV factors, activating type I IFN expression, activating CD8+ T cells, facilitating infiltration in cancer tissues, and promoting DC differentiation in melanoma147. The gene discussed is CD8A; the disease is cancer.